Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · May 30, 2018

Aldosterone Antagonist Therapy and Mortality in Patients With STEMI Without Heart Failure

JAMA Internal Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Internal Medicine
Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-Analysis
JAMA Intern Med 2018 May 21;[EPub Ahead of Print], K Dahal, A Hendrani, SP Sharma, S Singireddy, G Mina, P Reddy, Pi Dominic, K Modi

Further Reading